Jpn. J. Infect. Dis., 65 (4), 350-353, 2012
To see a printable version of the article in the Adobe file format, click this [PDF] link.
Bishi Fu1,2, Rongge Yang2, Fan Xia3, Baolin Li1,2, Xinxing Ouyang1,2, Shou-Jiang Gao4, and Linding Wang1,2*
1Department of Microbiology, Anhui Medical University, Hefei; 2State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan; 3College of Biological Science, Yangtze University, Hubei, China; and 4Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
(Received November 2, 2011. Accepted April 18, 2012)
*Corresponding author: Mailing address: Department of Microbiology, Anhui Medical University, Hefei, 230032, China. Tel & Fax: +86-551-5123422, E-mail: このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。
SUMMARY: Kaposi's sarcoma-associated herpesvirus (KSHV) is the causal agent of Kaposi's sarcoma (KS), a common cancer in patients with acquired immunodeficiency syndrome. The risk factors for KSHV infection have been extensively studied for Western countries but remain largely undefined for other parts of the world. Schistosomiasis, caused by Schistosoma japonicum infection, was recently identified as a cofactor for KSHV infection in rural Egypt. In this study, we examined the seroprevalence of KSHV in a population along the Yangtze River in China that has a high incidence of schistosomiasis. KSHV seroprevalence in subjects with schistosomiasis was slightly higher than that in subjects without schistosomiasis, but the difference was not statistically significant (8.4% versus 6.6%; P = 0.204). However, after adjusting for gender, KSHV seroprevalence in men with schistosomiasis was found to be significantly higher than that in men without schistosomiasis (8.4% versus 2.8%; odds ratio [OR], 3.170; 95% confidence interval [CI], 1.501–6.694; P = 0.002). Compared to men, women showed significantly higher seroprevalence of KSHV (5.9% versus 9.3%; OR, 1.621; 95% CI, 1.084–2.425; P = 0.019).
